Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

EGFR-mutated lung adenocarcinoma patients who received tyrosine kinase inhibitors (TKIs) may initially respond to therapy, but over time, resistance eventually occurs. In a small population (5–10%), these patients can have a histological transformation to SCLC. Nine patients with EGFR-mutated lung a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mambetsariev, Isa, Arvanitis, Leonidas, Fricke, Jeremy, Pharaon, Rebecca, Baroz, Angel R., Afkhami, Michelle, Koczywas, Marianna, Massarelli, Erminia, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911080/
https://www.ncbi.nlm.nih.gov/pubmed/35268520
http://dx.doi.org/10.3390/jcm11051429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911080/
https://www.ncbi.nlm.nih.gov/pubmed/35268520
http://dx.doi.org/10.3390/jcm11051429

Ejemplares similares